Matches in Nanopublications for { ?s ?p "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP198801.RAMmonGVQ_OymdyFI5WKUYrjR86DAKJJNM4rygFR0yvhg130_assertion description "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198801.RAMmonGVQ_OymdyFI5WKUYrjR86DAKJJNM4rygFR0yvhg130_provenance.
- NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_assertion description "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_provenance.
- NP558083.RAQnmRnNJ-HEtcGDa4BBC62U1LCuMDM7rD48XxEWPTuZg130_assertion description "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558083.RAQnmRnNJ-HEtcGDa4BBC62U1LCuMDM7rD48XxEWPTuZg130_provenance.
- NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_assertion description "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924510.RA0fOUssiXu2xEAnpv_PIF4k0TkkQkI-v_2Hud3sFIK70130_provenance.
- NP748937.RATWvct3d5fiswoNb8WAlCt6Hmr1B6W1mKQ0-RIuMf2Lo130_assertion description "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748937.RATWvct3d5fiswoNb8WAlCt6Hmr1B6W1mKQ0-RIuMf2Lo130_provenance.
- assertion description "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP580346.RAAehtRIp0w2K9JszSx6paHCyYOYgyDrJCxJb4pLaWVMY130_assertion description "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580346.RAAehtRIp0w2K9JszSx6paHCyYOYgyDrJCxJb4pLaWVMY130_provenance.